Gliclazide + Pioglitazone + Metformin
Information about Gliclazide + Pioglitazone + Metformin
Gliclazide + pioglitazone + metformin uses
Gliclazide+Pioglitazone+Metformin is used in the treatment of type 2 diabetes.
How gliclazide + pioglitazone + metformin works
This is a combination of three antidiabetic medicines: Gliclazide, Pioglitazone and Metformin. They work by different mechanisms to provide better control of blood sugar when single or dual therapy is not effective. Gliclazide is a sulfonylurea which works by increasing the amount of insulin released by the pancreas in order to lower the blood glucose. Pioglitazone is a thiazolidinedione which increases insulin sensitivity. Metformin is a biguanide. It works by lowering glucose production in the liver, delaying glucose absorption from intestines and further increasing the body's sensitivity to insulin.
Common side effects of gliclazide + pioglitazone + metformin
Hypoglycemia (low blood sugar level), Nausea, Altered taste, Diarrhoea, Stomach pain, Headache, Edema (swelling), Weight gain, Blurred vision, Bone fracture, Respiratory tract infection
Available Medicine for Gliclazide + Pioglitazone + Metformin
- ₹71 to ₹103Ipca Laboratories Ltd4 variant(s)
- ₹66 to ₹111Micro Labs Ltd2 variant(s)
- ₹77 to ₹92Panacea Biotec Ltd2 variant(s)
- ₹76 to ₹116Sun Pharmaceutical Industries Ltd3 variant(s)
- ₹96 to ₹115Eris Life Sciences Pvt Ltd2 variant(s)